Advertisement

Organisation › Details
ArchiMed MED III Fund
![]() |
Start | 2021-08-05 closing, final |
Group | ArchiMed (Group) | |
Predecessor | ArchiMed MED II Fund | |
![]() |
Industry | ArchiMed MED III Fund |
Industry 2 | HEALTH (HUMAN) | |
![]() |
Region | Lyon |
Country | France | |
City | n. a. | |
Address record changed: 2023-12-04 | ||
Basic data | Employees | n. a. |
Currency | EUR | |
Annual sales | 650,000,000 (fund size at closing (2021) 2021-08-05) | |
Record changed: 2024-02-12 |
Advertisement

More documents for ArchiMed (Group)
- [1] ArchiMed SAS. (10/7/22). "Press Release: ArchiMed Invests in PlasmidFactory, a German Gene and Cell Therapy Specialist"....
- [2] ArchiMed SAS. (11/3/21). "Press Release: ArchiMed Buys Cube, an Innovative Provider of Membrane Protein Services for the Biopharma Research Market"....
- [3] ArchiMed SAS. (10/5/21). "Press Release: ArchiMed Backs Xpress Biologics, a Leading Provider of Plasmid DNA for Advanced Therapy Medicinal Products"....
- [4] Clean Cells SAS. (9/15/21). "Press Release: Clean Cells Invests over €13M in New Biopharmaceutical Production Site". Montaigu-Vendée, near Nantes....
- [5] ArchiMed SAS. (8/5/21). "Press Release: ArchiMed Closes MED III at €650 Million Hard Cap in Less than Two Months"....
- [6] ArchiMed SAS. (1/12/21). "Press Release: ArchiMed Buys Germany’s Zyto Group of Cancer Diagnostics Companies in Partnership with Owners and Management"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top